GB1169740A - Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes - Google Patents

Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes

Info

Publication number
GB1169740A
GB1169740A GB2428469A GB2428469A GB1169740A GB 1169740 A GB1169740 A GB 1169740A GB 2428469 A GB2428469 A GB 2428469A GB 2428469 A GB2428469 A GB 2428469A GB 1169740 A GB1169740 A GB 1169740A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
gonanes
5alpha
estrus
haloalkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2428469A
Inventor
Jean Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GB2428469A priority Critical patent/GB1169740A/en
Publication of GB1169740A publication Critical patent/GB1169740A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

1,169,740. Compositions comprising steroids. MERCK & CO. Inc. 20 Oct., 1966, No. 24284/69. Divided out of 1,169,739. Addition to 1,169,739. Heading A5B. Pharmaceutical compositions comprise a diluent or carrier and a compound of the general formula: wherein R 1 is H or Me; and each of Z and Z, is C 1-6 alkyl or haloalkyl or a C 2-6 alkenyl, alkynyl, haloalkenyl or haloalkynyl. They are stated to be useful for the control of estrus in mammals.
GB2428469A 1966-10-20 1966-10-20 Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes Expired GB1169740A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2428469A GB1169740A (en) 1966-10-20 1966-10-20 Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2428469A GB1169740A (en) 1966-10-20 1966-10-20 Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes

Publications (1)

Publication Number Publication Date
GB1169740A true GB1169740A (en) 1969-11-05

Family

ID=10209284

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2428469A Expired GB1169740A (en) 1966-10-20 1966-10-20 Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes

Country Status (1)

Country Link
GB (1) GB1169740A (en)

Similar Documents

Publication Publication Date Title
ES360352A1 (en) 4-(betahydroxyethoxy-2-hydroxy-benzophenones) and esters thereof
ES389371A1 (en) Certain 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2) compounds
GB1334138A (en) Immunological adjuvatns
ES389180A1 (en) 1-amino-3(or4)-phenyl-3,4-dehydroisoquinolines
IE32174B1 (en) New compositions of matter
CA976777A (en) Agents for influencing the growth of plants
GB1169740A (en) Pharmaceutical Compositions Comprising A-nor-5alpha-Gonanes
GB1281719A (en) Anti-haemorrhoidally active preparations for local or rectal administration
ES366271A1 (en) 15, 16 substituted steroids and derivatives
GB1256995A (en)
GB1360979A (en) Veterinary compositions
GB1272340A (en) Derivatives of neriifolin
GB1355663A (en) 19-nortestosterone 17- -p-substituted phenoxy-acetates
CA931145A (en) Agent for the regulation of plant growth
GB1054632A (en)
ES375061A1 (en) Sulphamido-steroids and the preparation thereof
ES428823A1 (en) N(6)-disubstituted adenosine compounds
CH452187A (en) Process for preparing a stable foam-generating composition
GB1177009A (en) Improvements in or relating to 9alpha, 11beta-Dichloro-Pregnane Compounds
GB1126134A (en) Novel acyl ureas and process means for the production thereof
GB1335321A (en) Nortropinone derivatives
ES347230A1 (en) Estratrienes, Processes for their Preparation, and Compositions Incorporating them
CA505957A (en) Synthesis of 1,5-ketoaldehydes
GB1172086A (en) Pharmaceutical preparations containing 1,2alpha-Methylene-Steroids
GB1152672A (en) 11-Oxygenated-16-methylene-17alpha-alkoxy Steroids